1. 2014 Final analysis of the PEAK trial: Overall survival (OS) and tumour responses during first-line treatment with mFOLFOX6 + either panitumumab (pmab) or bevacizumab (bev) in patients (pts) with metastatic colorectal carcinoma (mCRC). (September 2015) Authors: Rivera, F.; Karthaus, M.; Hecht, J.R.; Fasola, G.; Canon, J.L.; Guan, X.; Demonty, G.; Schwartzberg, L.S. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S332 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 2128 Early tumour shrinkage (ETS) and depth of response (DpR) with first-line panitumumab (P) plus FOLFOX4 (P-FOLFOX4) or FOLFIRI (P-FOLFIRI) in patients (pts) with wild-type (WT) RAS colorectal cancer (CRC) and liver-limited disease (LLD). (September 2015) Authors: Abad, A.; Massuti, B.; Gravalos, C.; Escudero, P; Guillen-Ponce, C.; Manzano, J.L.; Ortiz, M.J.; Safont, M.J.; Gallego, J.; Sastre, J.; Pericay, C.; Duenas, R.; Rivera, F.; Losa, F.; Valladares-Ayerbes, M.; Gonzalez, E.; Robles, L.; Aranda, E.; Carrato, A. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S374 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial. (15th October 2014) Authors: Élez, E.; Kocáková, I.; Höhler, T.; Martens, U. M.; Bokemeyer, C.; Van Cutsem, E.; Melichar, B.; Smakal, M.; Csőszi, T.; Topuzov, E.; Orlova, R.; Tjulandin, S.; Rivera, F.; Straub, J.; Bruns, R.; Quaratino, S.; Tabernero, J. Journal: Annals of oncology Issue: Volume 26:Number 1(2015:Jan.) Page Start: 132 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Comparison of experimental and CFD mass transfer coefficient of three commercial turbulence promoters. (1st March 2016) Authors: Lira-Teco, J.E.; Rivera, F.; Farías-Moguel, O.; Torres-González, J.; Reyes, Y.; Antaño-López, R.; Orozco, G.; Castañeda-Zaldivar, F. Journal: Fuel Issue: Volume 167(2016) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comparison of experimental and CFD mass transfer coefficient of three commercial turbulence promoters. (1st March 2016) Authors: Lira-Teco, J.E.; Rivera, F.; Farías-Moguel, O.; Torres-González, J.; Reyes, Y.; Antaño-López, R.; Orozco, G.; Castañeda-Zaldivar, F. Journal: Fuel Issue: Volume 167(2016) Page Start: 337 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Crescentic glomerulonephritis: data from the Spanish Glomerulonephritis Registry. Issue 5 (May 2015) Authors: Quiroga, B.; Vega, A.; Rivera, F.; López‐Gómez, J. M.; the Spanish Registry of Glomerulonephritis Journal: Internal medicine journal Issue: Volume 45:Issue 5(2015) Page Start: 557 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Factors associated with life satisfaction of adolescents living with employed and unemployed parents in Spain and Portugal: A person focused approach. (March 2020) Authors: Moreno-Maldonado, C.; Jiménez-Iglesias, A.; Camacho, I.; Rivera, F.; Moreno, C.; Matos, M.G. Journal: Children and youth services review Issue: Volume 110(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study. (September 2018) Authors: Aranda, E.; García-Alfonso, P.; Benavides, M.; Sánchez Ruiz, A.; Guillén-Ponce, C.; Safont, M.J.; Alcaide, J.; Gómez, A.; López, R.; Manzano, J.L.; Méndez Ureña, M.; Sastre, J.; Rivera, F.; Grávalos, C.; García, T.; Martín-Valadés, J.I.; Falcó, E.; Navalón, M.; González Flores, E.; M García Tapia... Journal: European journal of cancer Issue: Volume 101(2018) Page Start: 263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. First-line single-agent panitumumab in frail elderly patients with wild-type KRAS metastatic colorectal cancer and poor prognostic factors: A phase II study of the Spanish Cooperative Group for the Treatment of Digestive Tumours. Issue 11 (July 2015) Authors: Sastre, J.; Massuti, B.; Pulido, G.; Guillén-Ponce, C.; Benavides, M.; Manzano, J.L.; Reboredo, M.; Rivera, F.; Grávalos, C.; Safont, M.J.; Martínez Villacampa, M.; Llovet, P.; Dotor, E.; Díaz-Rubio, E.; Aranda, E.; Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD) Journal: European journal of cancer Issue: Volume 51:Issue 11(2015:Jul.) Page Start: 1371 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Gold glyconanoparticles coupled to listeriolysin O 91–99 peptide serve as adjuvant therapy against melanoma. Issue 30 (17th July 2017) Authors: Calderon-Gonzalez, R.; Terán-Navarro, H.; García, I.; Marradi, M.; Salcines-Cuevas, D.; Yañez-Diaz, S.; Solis-Angulo, A.; Frande-Cabanes, E.; Fariñas, M. C.; Garcia-Castaño, A.; Gomez-Roman, J.; Penades, S.; Rivera, F.; Freire, J.; Álvarez-Domínguez, C. Journal: Nanoscale Issue: Volume 9:Issue 30(2017) Page Start: 10721 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗